Back to Search

Assessing the utility of genomic and epigenomic signatuRes in circulating tuMOR DNA in patients with advanced solid tumors (ARMOR Trial)


  • Protocol Number: 202509059
  • Principal Investigator: Davis, Andrew
  • Cancer Types: Breast, Gastrointestinal, GU: Bladder, Kidney, Prostate, Testicular, Lung, Melanoma & Skin

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]